Literature DB >> 12045343

New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells.

Jiang-Jing Gao1, Byung-Sun Min, Eun-Mi Ahn, Norio Nakamura, Hyeong-Kyu Lee, Masao Hattori.   

Abstract

Three new lanostante-type triterpene aldehydes, named lucialdehydes A-C (1-3), were isolated from the fruiting bodies of Ganoderma lucidum, together with ganodermanonol (4), ganodermadiol (5), ganodermanondiol (6), ganodermanontriol (7), ganoderic acid A (8), ganoderic acid B8 (9), and ganoderic acid C1 (10). The structures of the new triterpenes were determined as (24E)-3 beta-hydroxy-5 alpha-lanosta-7,9(11),24-trien-26-al (1), (24E)-3,7-dioxo-5 alpha-lanosta-8,24-dien-26-al (2), and (24E)-3 beta-hydroxy-7-oxo-5 alpha-lanosta-8,24-dien-26-al (3), respectively, by spectroscopic means. The cytotoxicity of the compounds isolated from the ganoderma mushroom was tested in vitro against Lewis lung carcinoma (LLC), T-47D, Sarcoma 180, and Meth-A tumor cell lines. Lucialdehydes B, C (2, 3), ganodermanonol (4) and ganodermanondiol (6) showed cytotoxic effects on tested tumor cells. Of the compounds, lucialdehyde C (3) exhibited the most potent cytotoxicity against LLC, T-47D, Sarcoma 180, and Meth-A tumor cells with ED(50) values of 10.7, 4.7, 7.1, and 3.8 microg/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045343     DOI: 10.1248/cpb.50.837

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  18 in total

1.  Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients.

Authors:  Changda Liu; Nan Yang; Ying Song; Lixin Wang; Jiachen Zi; Shuwei Zhang; David Dunkin; Paula Busse; David Weir; Jody Tversky; Rachel L Miller; Joseph Goldfarb; Jixun Zhan; Xiu-Min Li
Journal:  Int Immunopharmacol       Date:  2015-05-21       Impact factor: 4.932

Review 2.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

Review 3.  The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis.

Authors:  Chia-Jui Weng; Gow-Chin Yen
Journal:  Clin Exp Metastasis       Date:  2010-05-12       Impact factor: 5.150

4.  Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells.

Authors:  Ben-Zion Zaidman; Solomon P Wasser; Eviatar Nevo; Jamal Mahajna
Journal:  Mol Biol Rep       Date:  2007-03-13       Impact factor: 2.316

5.  Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum.

Authors:  Qun Zhang; Feng Zuo; Norio Nakamura; Chao-Mei Ma; Masao Hattori
Journal:  J Nat Med       Date:  2009-05-01       Impact factor: 2.343

6.  FPOA induces the apoptosis of HepG2 cells.

Authors:  Mingjie Song; Haiying Bao; Tolgor Bau
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

Review 7.  Applications of Herbal Medicine to Treat Autosomal Dominant Polycystic Kidney Disease.

Authors:  Guangying Shao; Shuai Zhu; Baoxue Yang
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

8.  Interaction of ganoderic acid on HIV related target: molecular docking studies.

Authors:  Rahmad Akbar; Wai Keat Yam
Journal:  Bioinformation       Date:  2011-12-21

9.  The pharmacological potential of mushrooms.

Authors:  Ulrike Lindequist; Timo H J Niedermeyer; Wolf-Dieter Jülich
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

10.  Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs.

Authors:  A Berger; D Rein; E Kratky; I Monnard; H Hajjaj; I Meirim; C Piguet-Welsch; J Hauser; K Mace; P Niederberger
Journal:  Lipids Health Dis       Date:  2004-02-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.